Fusion-based ultrasound (US)-guided biopsy in a breast is challenging due to the high deformability of the tissue combined with the fact that the breast is usually differently deformed in CT, MR, and US acquisition which makes registration difficult.
INTRODUCTION
Cost effectiveness, high usability and real-time performance make ultrasound the first imaging modality to use for biopsy guidance. Unfortunately, ultrasound-guided biopsy is no longer possible if the lesion is US occult. In this case, an alternative solution for the patient is more expensive and time consuming MRI-guided biopsy. It becomes even more complicated for patients with contraindications to MRI for instance for patients with claustrophobia or metal implants.
A solution for this can be an ultrasound-guided biopsy based on image fusion where the lesion in the US image is localized based on a co -registration with images obtained from other imaging modalities. For instance, MRI -US guided prostate biopsy is already widely used in clinic [1] . Unfortunately, it is challenging to apply this technique in breast due to the large deformation introduced.
This possible solution based on MRI -US image fusion, has already been proposed for breast tissue in [2] . In this phantom study the phantom was fixed between two plates similar to those used MRI-guided biopsy. The phantom was repositioned using a detachable table. Because of the fixation, the phantom had the same shape during both MRI and US scanning which facilitated rigid image co-registration and in that way the problem related to deformations of the breast were circumvented.
In this work we demonstrate a different approach of ultrasound-guided breast biopsy of lesions applicable also to lesions that have low contrast with surrounding tissue or are not even visible with ultrasound. As a detection modality we used dedicated breast CT [3] . The primary challenges of the project are to enable registration between breast CT and ultrasound volumetric data without breast fixation to increase patient comfort. The 3D ultrasound imaging was performed with a dedicated setup where the breast was prone positioned during the scanning and not deformed.
Additionally, we propose the use of a speckle tracking algorithm [4] to improve targeting of the lesion when it is displaced from the registered position upon insertion of the biopsy needle [5] .
The method was validated using phantom experiments.
METHODS

System description and the workflow
The automated breast ultrasound scanning and biopsy (ABUS -BS) system is depicted in Fig. 1 brings the needle to the target, while getting real-time imaging feedback from the ultrasound probe which is in the same 2D plane. Finally the biopsy sample is taken.
System Design
An Acuson S2000 system is used for the US imaging and the data acquisition with the 152-mm-wide (768 elements) ABVS transducer. B-mode images are 60 mm in the axial direction. The transducer is mounted into a cone-shaped container. Due to the fixation, part of the transducer is blocked, leaving only 114.3 mm available for imaging (Fig. 2b) . The opening angle of the cone is 90 o and the diameter of the cone's base is 160 mm. The container's design allows breasts of cup size A and B to hang free inside of the container and to be naturally aligned by the gravity alike the breast CT scanning. The cone is filled with water as an acoustic coupling medium.
An array of through holes (2.5 mm diameter and 1.5 mm gap in between apertures) on the opposite of the transducer side facilitates the biopsy. The holes provide needle steering in parallel to the transducer surface. This design prevents any contact between the transducer and the needle to avoid damaging.
The container is actuated by the closed loop stepper motor ARM69AC (Oriental Motor, Torrance, USA) that revolves 360 o in 60 seconds. During the revolution 316 US frames (1.13° between acquired US frames) are acquired by the US system. The total duration of the US image acquisition is 60 sec. The motor's revolution is triggered with encoding pulses from the stepper motor of the ABVS robotic arm. Acquired volumetric DICOM data are then uploaded into the custom SW and volumetric image reconstruction and registration with the breast CT image are performed, followed by the biopsy navigation.
The 3D volume is reconstructed from the cloud of points by assigning to each voxel the median value of pixels [6] , belonging to the voxel. The holes remaining after the reconstruction are filled with linear interpolation. The cloud of points is formed by transforming each pixel of each initial B-mode image p 0 into a corresponding location of the cone's spatial coordinate system using linear transformation 1. 
Where p 0 represents the pixels belonging to the US image, H is the transformation matrix from the transducer's coordinates to the cone's coordinates, Rz and Ry are rotation matrixes representing rotation around z and y axis respectively, w is the width of the transducer, n is the number of acquired frames. A resulting 3D US volume of the phantom is depicted in Fig. 5 .
Next, a rigid marker based registration was performed to localize the lesion in the cone originated coordinate system. The marker segmentation was performed manually by the sonographer on both 3DUS and CT images. On the screening image radiologist also needs to segment the lesions to be biopsied. Next, the CT volume is registered to US image in cone originated coordinate system using gradient decent algorithm. After the lesion localization, SW outputs the angle ( equation 5) to rotate the cone until the center of the lesion belongs the transducers plane and number of biopsy aperture to use for the intervention, and the distance from the aperture to the center of the lesion. where v t is a vector collinear to the transducers lateral direction, v b -vector collinear to opposite the transducer cone forming line, ∆ -distance between centers of two biopsy apertures (4 mm).
Phantom validation
The procedure was validated on a breast phantom with 8 lesions:4 lesions of 7 mm in diameter and 4 lesions of 13 mm in diameter. The phantom was fabricated by dissolving poly vinyl alcohol (PVA) (Acros organics, Geel, Belgium) in antifreeze liquid and adding 1% of Silica gel 60 (Merck KGaA, Darmstadt, Germany)to create a homogenous speckle pattern.
The lesions were fabricated first by using 10% of PVA, 84% of antifreeze liquid and 5% of black paint. The dissolved PVA was poured into spherical mold and then frozen once. Next, the lesions were fixed inside of the breast mold.
The phantom was fabricated by using 5% PVA and 94% of antifreeze liquid. The 22 o solution was poured into the breast mold and frozen.
The lesions did not have a perfect spherical shape because of the groove formed during the manufacturing. Both lesions and phantoms contain the same concentration of silicon particles for the homogeneous speckle pattern.
The phantom was biopsied 5 times with a 16G ACECUT biopsy needle (TSK Laboratory, Japan) and the number of successfully biopsied lesion was assessed by visually assessing the presence of staining. of all pixels w current. In th accuracy, onl displacement by pushing th
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The displacem The results of During the m based method mismatch caused a deviation of the needle from the initial trajectory and consequent mistargeting. The same situation happened while targeting the second lesion. Due to the deviation was not so large and thanks to the prior information about the lesion remoteness from the cones wall, it was still possible to biopsy the lesion. In 3 other cases, the needle was visible in ultrasound image and the needle was following preplanned path. The recommended value for the aperture holes would be 1.3 mm diameter. This will decrease the chance of mistargeting.
A second possible reason that can result in a failed biopsy in vivo is lesion motion induced by the needle insertion. Although in the described experiment the needle insertion did not cause the lesion to move, this has been described before for in vivo measurements. Nevertheless, we demonstrated that the cross-correlation-based method can provide an accurate lesion tracking giving the radiologist the opportunity to correct the in plane needle position during biopsy.
CONCLUSION
The project introduces a method for image-fusion-based ultrasound-guided breast biopsy. It is demonstrated that ultrasound-guided biopsy of low contrast or ultrasound occult lesions is possible by using image fusion and tissue displacement estimation. Potentially, this method can be clinically used and be an alternative to MRI-guided biopsy.
